Impact of PIK3CA and cell cycle pathway genetic alterations on durvalumab efficacy in patients with head and neck squamous cell carcinoma: Post hoc analysis of TRIUMPH study
- Dong Hyun Kim
- , Seung Taek Lim
- , Hye Ryun Kim
- , Eun Joo Kang
- , Hee Kyung Ahn
- , Yun Gyoo Lee
- , Der Sheng Sun
- , Jung Hye Kwon
- , Sang Cheol Lee
- , Hyun Woo Lee
- , Min Kyoung Kim
- , Bhumsuk Keam
- , Keon Uk Park
- , Seong Hoon Shin
- , Hwan Jung Yun
- Seoul National University
- Yonsei University Mirae Campus
- Yonsei University
- Korea University
- Gachon University
- Kangbuk Samsung Hospital
- Chungnam National University
- Soonchunhyang University
- Ajou University
- Yeungnam University
- Keimyung University
- Kosin University
Research output: Contribution to journal › Article › peer-review
6
Scopus
citations